Identification and single-base gene-editing functional validation of a cis-EPO variant as a genetic proxy for EPO-increasing therapies.

Summary statistics for the genome-wide association study meta-analysis of circulating EPO in 6,127 individuals of European and African American descent. Effect sizes are aligned to allele 1. 

Description of column names:
# Marker    - this is the marker name; chromosome:position
# Allele1   - the first allele for this marker in the first file where it occurs
# Allele2   - the second allele for this marker in the first file where it occurs
# Freq1       - weighted average of frequency for allele 1 across all studies
# FreqSE      - corresponding standard error for allele frequency estimate
# MinFreq     - minimum frequency for allele 1 across all studies
# MaxFreq     - maximum frequency for allele 1 across all studies
# Effect    - overall estimated effect size for allele1
# StdErr    - overall standard error for effect size estimate
# P-value   - meta-analysis p-value
# Direction - summary of effect direction for each study, with one '+' or '-' per study. Order of the studies is InCHIANTI, BLSA, HealthABC Europeans, PREVEND, HealthABC African Americans
# HetISq    - I^2 statistic which measures heterogeneity on scale of 0-100%
# HetChiSq  - chi-squared statistic in simple test of heterogeneity
# df        - degrees of freedom for heterogeneity statistic
# HetPVal   - P-value for heterogeneity statistic
# TotalSampleSize - overall sample size for that variant in the meta-analysis